These findings demonstrated that the targeting ABL gene have similar anti-cancer effect of targeting BCR-ABL gene, causing a dramatic suppression of both cell viability and cell proliferation in CML cells. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.